No Posts
SKN | Is Roivant Sciences’ Upside Now a 2026 Story as Catalysts and Litigation Reprice the Risk?
Roivant Sciences’ investment narrative has shifted into a more compressed and disciplined framework rather than
- Lior mor
- •
- 6 Min Read
- •
- 3 months ago












